Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study

<br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions"><strong>Background: </strong>A serogroup A meningococcal polysaccharide–tetanus toxoid conjugate vaccine (PsA–TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its s...

Full description

Bibliographic Details
Main Authors:	Daugla, D, Gami, J, Gamougam, K, Naibei, N, Mbainadji, L, Narbé, M, Toralta, J, Kodbesse, B, Ngadoua, C, Coldiron, M, Fermon, F, Page, A, Djingarey, M, Hugonnet, S, Harrison, O, Rebbetts, L, Tekletsion, Y, Watkins, E, Hill, D, Caugant, D, Chandramohan, D, Hassan-King, M, Manigart, O, Nascimento, M, Woukeu, A, Trotter, D, Stuart, J, Maiden, M, Greenwood, B
Format:	Journal article
Published:	Elsevier 2013

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study

Similar Items